Literature DB >> 28972861

Transcription Factor YY1 Modulates Lung Cancer Progression by Activating lncRNA-PVT1.

Tonghai Huang1, Guangsuo Wang1, Lin Yang1, Bin Peng1, Yuxin Wen1, Guanggui Ding1, Zheng Wang1.   

Abstract

Lung cancer is the leading cause of cancer-related death worldwide. Despite the advancement in surgery and chemotherapy, the prognosis of patients with advanced lung cancer is still poor. Yin Yang-1 (YY1) is a multifunctional transcription factor that exhibits positive and negative control on a large number of cellular and viral genes. In this study, we showed that the expression of YY1 is upregulated in lung cancer tissues as compared to adjacent normal tissues. Patients with higher expression of YY1 had larger tumor size, poor differentiation, higher TNM stage, and lymph node metastasis. Ectopic expression of YY1 in lung cancer cells promoted cell proliferation and invasion. Inversely, siRNA-mediated silencing of YY1 inhibited cell proliferation and induced apoptosis. These results suggested that YY1 may function as an oncogene in lung cancer. Moreover, through luciferase reporter assay, electrophoretic mobility shift assay, and chromatin immunoprecipitation assay, we showed that YY1 could directly bind to the promoter region of (long noncoding RNA-plasmacytoma variant translocation 1 [lncRNA-PVT1]) and activated its transcription through the consensus YY1 motif. Knockdown of the expression of YY1 reduced cell proliferation in vivo, consistent with the results obtained from silencing the expression of YY1 in lung cancer cells. Collectively, our study showed a critical role of YY1 in the regulation of tumorigenesis, partly through its downstream target PVT1.

Entities:  

Keywords:  PVT1; YY1; lung cancer; transcriptional activation

Mesh:

Substances:

Year:  2017        PMID: 28972861     DOI: 10.1089/dna.2017.3857

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  41 in total

Review 1.  Functions of lncRNA DUXAP8 in non-small cell lung cancer.

Authors:  Cui Wu; Wu Song; Zhongnan Wang; Bingmei Wang
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.316

2.  Transcription factor NFIC functions as a tumor suppressor in lung squamous cell carcinoma progression by modulating lncRNA CASC2.

Authors:  Hong Zhang; Zhilin Luo; JianMing Tang; Jie Tian; Yajie Xiao; Chao Sun; Tianhu Wang
Journal:  Cell Cycle       Date:  2022-01-05       Impact factor: 4.534

3.  KLF5-induced miR-487a augments the progression of osteosarcoma cells by targeting NKX3-1 in vitro.

Authors:  Anyu Luo; Hanlin Liu; Chen Huang
Journal:  Oncol Lett       Date:  2022-06-14       Impact factor: 3.111

Review 4.  Long Noncoding RNAs in Lung Cancer: From Disease Markers to Treatment Roles.

Authors:  Lin Chen; Yuxin Xie; Min Yu; Qiheng Gou
Journal:  Cancer Manag Res       Date:  2022-05-21       Impact factor: 3.602

Review 5.  Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer.

Authors:  Seng Chuan Tang; Udhaya Vijayakumar; Ying Zhang; Melissa Jane Fullwood
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

6.  Endothelial-specific YY1 governs sprouting angiogenesis through directly interacting with RBPJ.

Authors:  Shuya Zhang; Ji Young Kim; Suowen Xu; Huan Liu; Meimei Yin; Marina Koroleva; Jia Guo; Xiuying Pei; Zheng Gen Jin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-19       Impact factor: 12.779

Review 7.  Prognostic values of long noncoding RNA PVT1 in various carcinomas: An updated systematic review and meta-analysis.

Authors:  Meizhu Xiao; Ying Feng; Chongdong Liu; Zhenyu Zhang
Journal:  Cell Prolif       Date:  2018-09-05       Impact factor: 6.831

8.  The effects of LncRNA PVT1 on clinical characteristics and survival in breast cancer patients: A protocol for systematic review and meta analysis.

Authors:  Li Xie; Gang Feng; Ping Zhu; Jiang Xie
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

9.  SNHG1-miR-186-5p-YY1 feedback loop alleviates hepatic ischemia/reperfusion injury.

Authors:  Qiang Sun; Jinlong Gong; Jianlong Wu; Zhipeng Hu; Qiao Zhang; Xiaofeng Zhu
Journal:  Cell Cycle       Date:  2022-03-11       Impact factor: 5.173

Review 10.  Long non‑coding RNAs in lung cancer: Regulation patterns, biologic function and diagnosis implications (Review).

Authors:  Lin Jiang; Zheng Li; Ranran Wang
Journal:  Int J Oncol       Date:  2019-07-29       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.